Virobay's Series B - II Round

Virobay raised a round of funding on July 16, 2014.

Virobay is focused on the development and commercialization of novel drugs through the utilization of small molecule cysteine proteases inhibitors, a diverse class of enzyme proteases, for a variety o…

Articles about Virobay's Series B - II Round: